The anti-apoptotic Bcl2 family proteins are overexpressed in many hematological malignancies, including B-ALL, where it has been found in more than 66% patients compared to healthy donors [133]. This evidence concerns the gene BCL2 and precursor B-cell acute lymphoblastic leukemia.